John D. McCallion's most recent trade in Metlife Inc was a trade of 26,934 Common Stock done . Disclosure was reported to the exchange on Feb. 24, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| MetLife | John D. McCallion | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2026 | 26,934 | 295,955 (0%) | 0% | - | Common Stock | |
| MetLife | John D. McCallion | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2026 | 23,892 | 269,021 (0%) | 0% | - | Common Stock | |
| MetLife | John D. McCallion | EVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 75.34 per share. | 24 Feb 2026 | 13,776 | 282,179 (0%) | 0% | 75.3 | 1,037,884 | Common Stock |
| MetLife | John D. McCallion | EVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 85.70 per share. | 03 Mar 2025 | 5,232 | 245,129 (0%) | 0% | 85.7 | 448,382 | Common Stock |
| MetLife | John D. McCallion | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2025 | 52,211 | 277,065 (0%) | 0% | - | Common Stock | |
| MetLife | John D. McCallion | EVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 82.20 per share. | 25 Feb 2025 | 26,704 | 250,361 (0%) | 0% | 82.2 | 2,195,069 | Common Stock |
| MetLife | John D. McCallion | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2025 | 20,073 | 224,854 (0%) | 0% | - | Common Stock | |
| MetLife | John D. McCallion | EVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 69.73 per share. | 01 Mar 2024 | 5,164 | 204,781 (0%) | 0% | 69.7 | 360,086 | Common Stock |
| MetLife | John McCallion D. | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2024 | 71,915 | 244,558 (0%) | 0% | - | Common Stock | |
| MetLife | John McCallion D. | EVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 69.16 per share. | 27 Feb 2024 | 34,613 | 209,945 (0%) | 0% | 69.2 | 2,393,835 | Common Stock |
| MetLife | McCallion D. John | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2024 | 32,538 | 32,538 | - | - | Employee Stock Options (right to buy) | |
| MetLife | D. McCallion John | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2024 | 10,845 | 172,643 (0%) | 0% | - | Common Stock | |
| MetLife | John D. McCallion | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Aug 2023 | 11,841 | 161,798 (0%) | 0% | - | Common Stock | |
| MetLife | John D. McCallion | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2023 | 82,782 | 197,590 (0%) | 0% | - | Common Stock | |
| MetLife | John D. McCallion | EVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 71.73 per share. | 28 Feb 2023 | 42,256 | 155,334 (0%) | 0% | 71.7 | 3,031,023 | Common Stock |
| MetLife | John D. McCallion | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2023 | 30,113 | 30,113 | - | - | Employee Stock Options (right to buy) | |
| MetLife | John D. McCallion | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2023 | 10,038 | 114,808 (0%) | 0% | - | Common Stock | |
| MetLife | John D. McCallion | EVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 71.27 per share. | 28 Feb 2023 | 5,377 | 149,957 (0%) | 0% | 71.3 | 383,219 | Common Stock |
| MetLife | John D. McCallion | EVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 64.44 per share. | 01 Mar 2022 | 5,437 | 104,770 (0%) | 0% | 64.4 | 350,360 | Common Stock |
| MetLife | John D. McCallion | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2022 | 66,457 | 142,019 (0%) | 0% | - | Common Stock | |
| MetLife | John D. McCallion | EVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 68.96 per share. | 22 Feb 2022 | 31,812 | 110,207 (0%) | 0% | 69.0 | 2,193,756 | Common Stock |
| MetLife | John D. McCallion | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2022 | 29,361 | 29,361 | - | - | Employee Stock Options (right to buy) | |
| MetLife | John D. McCallion | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2022 | 9,789 | 75,562 (0%) | 0% | - | Common Stock |